A brand new type of cancer drug that acts as a ‘Trojan horse’ to get inside tumour cells has shown promise in patients with six different cancer types.

A cancer-driving protein is found in the tumours of men with advanced prostate cancer after treatment with hormone drugs, but rarely found in early-stage disease, a new study shows.

Colleagues from across cancer research, family and friends came together to celebrate and mark the achievements of the ICR's Professor Johann de Bono, as he delivered a celebratory lecture to mark his appointment as the ICR's first Regius Professor of Cancer Research.